跳至主要内容
临床试验/IRCT20180417039338N3
IRCT20180417039338N3招募中3 期

Effect of Nifedipine Administration Before Embryo Transfer on Pregnancy Rates in ICSI cycles, a double blind control trial study

Babol University of Medical Sciences0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 40 years(—)
性别
Female

入选标准

  • 1.Women 18-40 yr with BMI<38 undergo ICSI treatment and freeze embryo transfer candidate are participated in this study.2. Blood pressure >= 100/60, 3. FSH <14mli/IU. 4. abnormal uterus in HSG or hystroscopy. 5. who do not contraindicate the use of nifedipine, such as heart and liver 6. Patients who do not have a history of irregular heart rate or who do not use hypotention medication.

排除标准

  • Patients who have been taking medication with nifedipine over a month have interfered with drugs such as benzodiazepines, flecainide, imipramine, propafenone, azole antifungals, cimetidine, cyclosporine, erythromycin, quinidine, terfenadine, warfarin and theophylline. 2.Those who have blood pressure of 60/100 (mmHg) or less before embryo transfer

研究者

相似试验